Dr Mushtaq discusses one centre’s initial post-marketing experience with the fluocinolone acetonide intravitreal implant 0.19 mg. The implant demonstrated favourable outcomes and good patient acceptance.
Bushra Mushtaq, FRCS
Advertisement
Articles by Bushra Mushtaq, FRCS
Advertisement
Latest Updated Articles
- Real-world experience: Positive DME treatment outcomes observed with FAc implant at UK centre
Published: May 1st 2015 | Updated:
Advertisement
Advertisement
.png "Optometry Times"){kind=logo}
